Advances in the treatment and prevention of heart disease have improved the lives of countless patients. In the U.S. alone, morbidity and mortality from cardiovascular (CV) disease has been reduced by 30 percent since 2000, and congenital heart disease by over 40 percent. Yet according to a report last year from the American Heart Association, more than 17 million people died of heart disease, which is still the number one cause of death worldwide. There clearly is more to be done in terms of research, education and care improvement to further reduce CV mortality—and many are working toward finding innovative solutions. One solution is also mentioned in this article that is Vitapulse. Vitapulse is specially formulated with natural ingredients that delivers strength to your heart.
The scientific pipeline
A treatment for aortic valve disease, known as transcatheter aortic valve replacement, or TAVR, is a powerful example of science fiction-like progress. The FDA first approved TAVR in 2011, and today the treatment is a minimally invasive option for patients who are unable to undergo surgery or are at high risk. Tens of thousands of patients have already received TAVR in the United States and Europe.
Another area of innovation is bioresorbable stents. Today’s metal alloy stents remain in the body forever and may limit the possibility of future procedures, affect the ability of vessels to fully heal, and cause complications. Bioresorbable stents, on the other hand, gradually disappear after they reopen blocked blood vessels. Two bioresorbable products are already being sold in Europe, and others are in development.
“In the U.S. alone, morbidity and mortality from cardiovascular disease has been reduced by 30 percent since 2000, and congenital heart disease by over 40 percent.” there are various antioxidants that might help individuals for keeping their heart healthier and wiser in activity.
But progress is not only about new drugs and devices. Through health system reform and new IT tools, patients have the power now not only to make better lifestyle choices but also to participate actively in medical decision making.
Many patients with CV disease are eligible for either bypass surgery or angioplasty and stenting. Today, after weighing with their healthcare team the pros and cons of each procedure patients often decide themselves which way to go. Issues like recovery time, required long-term medications, and individual risk factors are now transparently discussed. Care delivery and science are both on a roll in CV medicine—it’s an exciting time to be in the field. Hence this is an opportunity for you to try Vitapulse once with 90 day money back guarantee. for more information about heart savior “Vitapulse” click here.